Bottom line
RMEAX vs FBALX: the short answer
RMEAX (Aspiriant Risk-Managed Equity Allocation Fund) and FBALX (Fidelity Balanced Fund) are both mutual funds.
But FBALX is far broader, holding 368 positions to 144 for RMEAX, so beyond the top names it adds exposure RMEAX doesn't have.
FBALX is cheaper at 0.44% vs 0.95% — a difference of $51 a year per $10,000 invested.
Over five years, FBALX returned +9.5% a year vs +9.2% for RMEAX (reporting dates differ).
Updated Nov 19, 2026
RMEAX vs FBALX side by side
| RMEAX | FBALX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Aspiriant | Fidelity |
| Category | Allocation / Balanced | Allocation / Balanced |
| Expense ratio | 0.95% | 0.44% |
| Annual cost per $10k | $95 | $44 |
| 10-yr cost on $10k (prospectus) | $1,305 | $555 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +17.7% | +15.2% |
| 5-yr return (annualized) | +9.2% | +9.5% |
| 10-yr return (annualized) | +8.8% | +11.1% |
| Best quarter | +9.8% | +18.3% |
| Worst quarter | −16.8% | −13.8% |
| Net assets (fund) | $1.4B | $65.8B |
| Number of holdings | 144 | 368 |
| Portfolio turnover | 21% | 36% |
| Returns as of | Dec 31, 2025 | Oct 31, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RMEAX | FBALX | Difference |
|---|---|---|---|
| 2025 | +17.7% | +15.2% | +2.5% |
| 2024 | +14.7% | +16.1% | −1.3% |
| 2023 | +16.2% | +21.6% | −5.4% |
| 2022 | −13.7% | −18.2% | +4.5% |
| 2021 | +14.8% | +18.3% | −3.5% |
| 2020 | +4.0% | +22.4% | −18.5% |
| 2019 | +16.8% | +24.4% | −7.6% |
| 2018 | −3.5% | −4.0% | +0.5% |
| 2017 | +21.8% | +16.5% | +5.3% |
| 2016 | +4.5% | +7.0% | −2.5% |
Source: Fund prospectus bar charts
Holdings overlap
10 of RMEAX's top 25 holdings also appear in FBALX's top 25.
| Holding | RMEAX | FBALX |
|---|---|---|
| Microsoft Corp. | 1.08% | 2.69% |
| Apple, Inc. | 0.94% | 3.70% |
| NVIDIA Corp. | 0.87% | 5.78% |
| Amazon.com, Inc. | 0.74% | 3.01% |
| Lam Research Corp. | 0.72% | 0.47% |
| Broadcom, Inc. | 0.67% | 1.80% |
| Alphabet, Inc. | 0.67% | 4.76% |
| Eli Lilly & Co. | 0.54% | 1.06% |
| Mastercard, Inc. | 0.53% | 1.04% |
| Meta Platforms, Inc. | 0.50% | 1.49% |
Source: SEC Form N-PORT
RMEAX top 10
- GMO Quality Fund — 34.47%
- Schwab Fundamental Emerging Markets Equity ETF — 7.19%
- Rief Strategic Partners Fund — 6.44%
- Baillie Gifford Emerging Markets Equities Fund — 5.66%
- GMO Investments ICAV - GMO Equity Dislocation Investment Fund — 4.32%
- AQR Large Cap Defensive Style Fund — 3.83%
- Viking Global Equities LP — 3.41%
- JPMorgan Prime Money Market Fund — 3.18%
- iShares MSCI Global Min Vol Factor ETF — 2.84%
- iShares MSCI ACWI ETF — 2.39%
FBALX top 10
- Fidelity Central Investment Portfolios II LLC — 33.70%
- Nvidia Corp — 5.78%
- Alphabet Inc — 4.76%
- Apple Inc — 3.70%
- Amazon.com Inc — 3.01%
- Microsoft Corp — 2.69%
- Broadcom Inc — 1.80%
- Meta Platforms Inc — 1.49%
- Micron Technology Inc — 1.35%
- Fidelity Revere Street Trust — 1.20%
FAQ
What is the difference between RMEAX and FBALX?
Which is cheaper, RMEAX or FBALX?
Should I own both RMEAX and FBALX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.